venBio Partners’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$131M Hold
4,639,304
46.72% 1
2025
Q4
$129M Hold
4,639,304
59.53% 1
2025
Q3
$116M Buy
4,639,304
+350,000
+8% +$7.76M 65.62% 1
2025
Q2
$75.5M Hold
4,289,304
65.78% 1
2025
Q1
$67.3M Hold
4,289,304
54.5% 1
2024
Q4
$82.2M Hold
4,289,304
48.17% 1
2024
Q3
$79.4M Hold
4,289,304
40.88% 1
2024
Q2
$80.6M Hold
4,289,304
34.83% 1
2024
Q1
$99.1M Sell
4,289,304
-630,200
-13% -$16.7M 35.17% 2
2023
Q4
$138M Buy
4,919,504
+654,832
+15% +$13.3M 20.68% 3
2023
Q3
$89M Hold
4,264,672
25.24% 2
2023
Q2
$64.6M Buy
4,264,672
+1,986,097
+87% +$19.2M 23.37% 3
2023
Q1
$18.4M Sell
2,278,575
-18,135
-0.8% -$160K 10.17% 4
2022
Q4
$25.8M Hold
2,296,710
8.01% 4
2022
Q3
$17.6M Sell
2,296,710
-4,741
-0.2% -$74.1K 4.08% 6
2022
Q2
$50.9M Sell
2,301,451
-1,859
-0.1% -$34.6K 14.48% 4
2022
Q1
$41.8M Hold
2,303,310
9.26% 4
2021
Q4
$33.1M Hold
2,303,310
5.97% 5
2021
Q3
$40.8M Hold
2,303,310
4.07% 4
2021
Q2
$42.9M Hold
2,303,310
5.06% 4
2021
Q1
$64.4M Buy
+2,303,310
New +$72.5M 6.12% 4

Other funds holding PHVS